| Dr Jerzy A Sopala, MD | |
|
132a W Miller St, Asheboro, NC 27203-4706 | |
| (336) 625-3248 | |
| (336) 625-6629 |
| Full Name | Dr Jerzy A Sopala |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 34 Years |
| Location | 132a W Miller St, Asheboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629055033 | NPI | - | NPPES |
| 89128JE | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Firsthealth Home Care | West end, NC | Home health agency |
| Firsthealth Hospice | West end, NC | Hospice |
| Hospice Of The Piedmont Inc | High point, NC | Hospice |
| Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
| Randolph Hospital | Asheboro, NC | Hospital |
| St Joseph Of The Pines Health Center | Pinehurst, NC | Nursing home |
| Clapp's Convalescent Nursing Home Inc | Asheboro, NC | Nursing home |
| Woodland Hill Center | Asheboro, NC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Healthcare Systems Llc | 7719383538 | 49 |
| Fhpg Llc | 9537481569 | 164 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | Piedmont Adult&geriatric Medicine, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437259983 PECOS PAC ID: 0941202808 Enrollment ID: O20070206000030 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | Quantum Health Group, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750407102 PECOS PAC ID: 3375635410 Enrollment ID: O20070822000363 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | Randolph Specialty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891756946 PECOS PAC ID: 0941371025 Enrollment ID: O20080617000534 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | Moses Cone Physician Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093953127 PECOS PAC ID: 4284782210 Enrollment ID: O20090501000202 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | Fhpg Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336154129 PECOS PAC ID: 9537481569 Enrollment ID: O20141202002644 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Entity Name | American Healthcare Systems Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194310235 PECOS PAC ID: 7719383538 Enrollment ID: O20210916001253 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerzy A Sopala, MD 2108 San Fernando Dr, High Point, NC 27265-9643 Ph: (336) 885-3058 | Dr Jerzy A Sopala, MD 132a W Miller St, Asheboro, NC 27203-4706 Ph: (336) 625-3248 |
News Archive
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
Obtaining therapy via teleconference is just as effective as face-to-face sessions, according to a new research by St-phane Guay, a psychiatry professor at the Universit- de Montr-al.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
› Verified 3 days ago
Charles S Betts, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1831 N Fayetteville St, Asheboro, NC 27203 Phone: 336-672-1300 Fax: 336-672-3044 | |
Dr. Dequincy Andrew Lewis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 713 S Fayetteville St, Suite B, Asheboro, NC 27203 Phone: 336-626-0033 | |
Ava M Swayze, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 336-830-9192 | |
Dr. Brian J Munley, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 542 White Oak St, Asheboro, NC 27203 Phone: 336-610-3720 | |
Dr. Shiv Kumar Harsh, M. D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 542 White Oak St, Asheboro, NC 27203 Phone: 336-629-4176 Fax: 336-626-6604 | |
Mrs. Nina Uppin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 237-a N. Fayetteville Street, Asheboro, NC 27203 Phone: 336-625-3248 Fax: 336-625-6629 | |
Patricia Ann Pierce, ANP Internal Medicine Medicare: Medicare Enrolled Practice Location: 138 Dublin Square Rd Ste B, Asheboro, NC 27203 Phone: 336-610-1300 Fax: 336-625-2163 |